Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review (Q34059272)

30 July 2017

0 references

1 reference

title

Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review (English)

1 reference

30 July 2017

0 references

premenstrual syndrome

1 reference

1 reference

P W Dimmock

1

1 reference

30 July 2017

K M Wyatt

series ordinal

2

1 reference

30 July 2017

P W Jones

series ordinal

3

1 reference

30 July 2017

P M O'Brien

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

356

1 reference

30 July 2017

9236

1 reference

30 July 2017

1131-1136

1 reference

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Serotonin and gender-specific psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Meta-analysis of screening and diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Open trial of fluoxetine therapy for premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Treatment of premenstrual syndrome with fluoxetine: an open study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Paroxetine as a treatment for premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Fluoxetine treatment of severe premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

A double-blind trial of four medications to treat severe premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Fluoxetine in the treatment of premenstrual dysphoria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Fluoxetine in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Fluvoxamine in the treatment of menstrually related mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Premenstrual syndromes: overview from a methodologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902754-9

7 January 2021

10.1016/S0140-6736(00)02754-9

Identifiers

DOI

1 reference

30 July 2017

1 reference